Comprehensive Eye Care & Vision Correction in Incheon · Multilingual International Concierge
23+ Years Clinical Experience
en-US
Ophthalmology Guide
ICL Surgery in Korea: A Complete Guide for US Patients
A clear guide to ICL surgery in Korea for US patients: what the phakic collamer lens is, candidacy, the procedure, recovery, and monitoring.
Schedule a ConsultationICL Surgery in Korea: A Complete Guide for US Patients
Medically reviewed by Dr. Heecheol Pae, Korean Board-Certified Ophthalmologist, Global Ubal Eye Center
What ICL Surgery Actually Is
An ICL is a posterior-chamber phakic intraocular lens. Breaking that phrase down helps explain what makes it different from other procedures. "Phakic" means your natural crystalline lens stays in place; the ICL does not remove or replace it. "Posterior chamber" describes where the lens sits inside the eye — behind the iris (the colored part) and in front of your natural lens.
FDA Status and What "Approved" Means Here
Regulatory precision matters when you are researching a medical device, so it is worth being exact. In the United States, the EVO/EVO+ Visian Implantable Collamer Lens (STAAR Surgical) received US Food and Drug Administration approval in March 2022 to correct myopia in adults ages 21 to 45, with a toric version approved for the correction of myopic astigmatism.
Who ICL Surgery May Suit
ICL is frequently discussed for people who fall into a few overlapping groups. It is often considered for those with higher degrees of myopia, where laser correction might require removing more corneal tissue than is advisable.
The Evaluation Before Surgery
A thorough pre-operative workup is central to ICL planning. During evaluation, the eye care team measures the shape and thickness of the cornea, maps the eye's optics, checks the anterior chamber depth to confirm there is adequate room for the lens, and counts the endothelial cells that keep the cornea clear.
What the Procedure Involves
ICL implantation is typically an outpatient microsurgical procedure performed on one eye at a time or on both, depending on the plan your surgeon sets. The eye is numbed, usually with drops, and the surgeon makes a very small opening at the edge of the cornea. The folded collamer lens is inserted through that opening and gently positioned behind the iris, in front of the natural lens.
Recovery and Follow-Up
Recovery after ICL surgery is often described as relatively quick, but experiences differ from person to person, and "quick" does not mean unmonitored. In the early period you will likely use prescribed eye drops to reduce the risk of infection and inflammation, and you will be given instructions about activities to avoid, such as rubbing the eyes, swimming, or exposing the eye to dust and water while it heals.
Risks and What Is Monitored Over Time
Every surgical procedure carries risks, and ICL is no exception. Understanding them is part of giving informed consent, and a responsible clinic will discuss them openly rather than minimize them.
Setting Realistic Expectations
It is natural to hope for a specific result, but honest expectations serve patients better than promises. Outcomes vary from person to person, and no ethical clinic can guarantee a particular level of vision or promise "20/20" for anyone. Some people still need glasses for certain tasks after surgery, and factors such as your starting prescription, your eyes' anatomy, and how you heal all influence the result.
Where ICL Fits at Global Ubal Eye Center
Global Ubal Eye Center is a comprehensive ophthalmology clinic in Incheon, South Korea, founded in 2002, offering a full range of eye care that includes lens implant surgery (ICL) alongside LASIK, LASEK, and SMILE, as well as cataract surgery, glaucoma care, retinal disease treatment, and more.
The Bottom Line
- ICL is a posterior-chamber phakic collamer lens placed inside the eye to correct myopia while keeping your natural lens; it is considered reversible because the lens can be removed.
- The EVO/EVO+ Visian ICL is US-FDA-approved (March 2022) for myopia in adults ages 21–45, with a toric version for myopic astigmatism; the presbyopia "EVO Viva" variant is not covered by that approval.
- ICL is often discussed for higher myopia, thinner corneas, or people who are not ideal LASIK candidates, but suitability is decided only by a comprehensive exam.
- Key items monitored include lens vaulting, endothelial cell density, intraocular pressure, and long-term cataract risk, with rare infection risk; follow-up is essential.
- Results vary and no specific vision outcome can be promised. Discuss your options and follow-up plan directly with the clinic.
Frequently Asked Questions
**Is ICL surgery permanent?**The correction is intended to be long lasting, but the lens itself is designed to be removable. Because the ICL is added to the eye rather than removing tissue, a surgeon can explant it if that ever becomes medically necessary. This reversibility is one difference from laser procedures, which permanently reshape the cornea.
More Articles
Continue reading our ophthalmology guides and vision care insights.
SMILE vs LASIK: Recovery Benchmarks for Vision Correction Care
South Korea has solidified its position as a global epicenter for ophthalmology, with the domestic LASIK and refractive surgery market projected to reach **USD 167.37 million by 2035**, growing at a steady CAGR of 8.54%.
Learn More
Prevalence of Myopia in Korea: The Value of Dream Lens Therapy
The prevalence of myopia among young people in South Korea has reached critical levels, often described as a "myopia epidemic." According to recent data from the **Korean National Health and Nutrition Examination Survey (KNHANES)**, the prevalence of myopia...
Learn More
Multidisciplinary Care: The Future of Korean Pediatric Eye Clinics
The landscape of pediatric eye care in South Korea is shifting rapidly. With nearly **21.9% of Korean children** estimated to be affected by various visual disorders according to nationwide health screenings, the demand for specialized intervention has never...
Learn More